Professor Dan Aderka

Leading Oncologist – Gastrointestinal Cancer

Position: Chairman of the Gastrointestinal Cancer Service. Head of GI Biology and Immunotherapy Program Sheba Medical Center.
Head of the Gastrointestinal Cancer Unit at the Assuta leading private hospital.
Consultant – Cell Regulation Department, Weizmann Institute. Member of the European group for international treatment guidelines development for colorectal tumors.

Hospital: Assuta Medical Center

Prof. Aderka is in the Forbes list of the best Israeli doctors

Qualified Medical Consultation Online, Second Opinion on Colorectal Cancer, Gastric Cancer, Pancreatic Cancer, Liver Cancer, Esophageal cancer

Ask Doctor

• colorectal cancer
• stomach cancer
• pancreas cancer
• liver cancer
• esophageal cancer
• immunotherapy of digestive cancer
• molecular tests

Currently, Prof. Aderka is a consultant to pharmaceutical companies. He initiates international research for innovative developments in biological and immunological drugs for the treatment of colorectal cancer, stomach and pancreatic cancer. He pays particular attention to a deep understanding of the biology and immunology of tumors of the gastrointestinal tract, as well as molecular biology and tests, trying to promote personalized therapy through collaboration with world leaders in this field in Europe and the USA.

Today prof. Aderka initiates several studies aimed at preventing relapse of intestinal tumors, severe metastatic relapses, as well as the search for a more effective combination of drugs for treating pancreatic tumors.

In addition, professor pays special attention to teaching and spreading the knowledge and experience that he gains every day among doctors at the Institute of Oncology and at the lectures to which he is invited to Europe, the United States and South America.

He graduated from the Medical Faculty of Tel Aviv University, then served in the Israel Defense Forces as part of an academic reserve as a military doctor, and then as part of the research and development department of the Medical Corps. At the end of the service, Professor Aderka specialized in internal medicine at the Medical Center. Linson, and in 1984 he moved to the Ichilov hospital as deputy head of the department of internal medicine.

At the same time, the oncologist conducted basic research at the Weizmann Institute, within the framework of which he was a patent partner in the development of Enbrel for the treatment of arthritis, which significantly changed the treatment for this disease and it is currently one of the 10 best-selling medicines in the world.

In 1987, prof. Aderka participated in research at the New York University Medical Center. Returning to Israel, he continued his research at the Weizmann Institute, working in the Department of Internal Medicine at the Ichilov Clinic.

In 1993, prof. Aderka began specializing in the Institute of Oncology Ichilov, where he was led by a desire to find a cure for cancer.

In 1998, he was appointed Head of the oncology department of the Ichilov Hospital, and in 2003 he moved to the Medical Center named after Chaim Sheba, where he founded the Oncology Department of the Digestive System, which is currently the leading center in the country.

Throughout his career, Professor Aderka considers that it is important to support the patient, using every percent chance to cure him, even if the prospect is not in his favor according to previous treatment results. Honor doctor as an Israeli leading oncologist of digestive system, continues to advocate that it is always necessary to look for an innovative, original, creative solution such as molecular tests and immunotherapy, in contrast to previously unsuccessful solutions.

Positions of professor Aderka

• 1984-1987, 1989-1993 – Deputy Director of the Department of Internal Medicine, Ichilov Hospital.
• 2003 – present – Department of Oncology of the Digestive System (oncogastroenterology) of the Chaim Sheba MC.
• 2008-2014 – Head of the Israeli community of gastrointestinal tumors.
• 2010 – present – European group for the development of guidelines for the treatment of gastrointestinal tumors.
• 2015 – present – Scientific Advisor to the Weizmann Institute.
• 2014 – today – Scientific and medical consultant for pharmaceutical companies.
• 2017 – Present – Molecular Medicine Consultant – Oncotest – Nature.

Academic activity

• Graduate of the medical faculty of Tel Aviv University.
• 1976-1979 – Served in the Israel Defense Forces as part of an academic reserve, combat role, and then in the research and development of the Medical Corps.
• 1979-1984 – Internship in Internal Medicine Department at Beilinson Hospital.
• 1983-1995 – Research at the Weizmann Institute.
• 1987-1989 – Research, NYU Medical Center – New York.
• 1993-2003 – Specialist in Oncology and responsible for the Department of Oncology at the Ichilov.
• Member of the Israeli Cancer Association.
• Member of ASCO
• Member of ESMO

Awards

The award of an outstanding doctor – Chaim Sheba Medical Center in 2017.